Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • M&A / Deals
  • A Spanish biotech banks $87M to make differentiated ADCs
  • M&A / Deals

A Spanish biotech banks $87M to make differentiated ADCs

BioPharma Dive

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Oncology

Read full story

pharminent June 4, 2026 (Last updated: June 4, 2026)

BioPharma Dive

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Oncology

Read full story

Post navigation

Previous: Legend surges on early data for ‘in vivo’ lymphoma cell therapy
Next: Cellares and TScan to assess automated manufacturing of TSC-101 therapy

Related Stories

  • M&A / Deals

Solstice Oncology secures $225m to drive porustobart’s development for cancer

pharminent September 10, 2026
  • M&A / Deals

UK’s Claret Capital raises 575m for European biotechs

pharminent September 7, 2026
  • M&A / Deals

GSK wagers up to $1.3B on a different kind of cancer drug

pharminent September 3, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.